July 16, 2019
Burlington, ON, July 16, 2019 — Rapid Dose Therapeutics Corp. (CSE: DOSE), (“RDT”) and Ukraine Pharma (the “Company”) announced today that they have signed a twelve month distribution agreement (the “Agreement”) to export QuickStrip™ nutraceutical products to Ukraine and a number of other Eastern European...
June 27, 2019
Burlington, ON and Vancouver, BC, June 27, 2019 — Rapid Dose Therapeutics Corp. (CSE: DOSE), (“RDT”) and Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company”) announced today that they have expanded the scope of their previously announced agreement (the “Agreement”) expanding the...
June 13, 2019
Licensee, Chemesis International Inc., begins efforts for distribution of QuickStrip™ across United States & Puerto Rico BURLINGTON, Ontario – June 13, 2019 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian life sciences company focused on innovative drug and active ingredient...
June 6, 2019
BURLINGTON, Ontario – June 6, 2019 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian leader in drug delivery solutions, is pleased to announce that Dr. Rina Carlini has been appointed Vice President, Research & Innovation. Dr. Carlini is an accomplished...
April 16, 2019
BURLINGTON, Ontario – April 16, 2019 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian life sciences company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it has signed a Distribution Agreement with TFB & Associates...
April 10, 2019
BURLINGTON, Ontario – April 10, 2019 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian leader in drug delivery solutions, is pleased to announce that Mr. Ian Fodie has been appointed Chief Financial Officer effectively immediately. Mr. Fodie replaces Mr. Lino...
March 13, 2019
BURLINGTON, Ontario – March 13, 2019 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian bio-technology company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it has signed a Memorandum of Understanding (“MOU”) February 27, 2019...
March 11, 2019
Burlington, Ontario – March 11, 2019– Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Corporation”) announces the grant of options to directors, officers, employees and consultants to purchase 4,526,000 common shares of the Corporation, exercisable at $0.82 per share at any time on or...
March 5, 2019
BURLINGTON, Ontario – March 5, 2019 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian bio-technology company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it has been successful in obtaining a summary judgment against CTT...
March 4, 2019
Burlington, Ontario — Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Corporation”) is pleased to announce the completion of a vertical amalgamation (the “Amalgamation”) with its wholly-owned subsidiary, Rapid Dose Therapeutics Inc., pursuant to section 177 of the Business Corporations Act (Ontario). The Amalgamation...